Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2003
06/24/2003US6583168 Sulfonated diarylrhodamine dyes
06/24/2003US6583139 Treatment of inflammatory diseases; inflammatory brain diseases such as multiple sclerosis; N-(Toluene-4-sulfonyl)-L-prolyl-4-(alpha -methylbenzyloxy)-L-phenylalanine; Very Late Antigen 4
06/24/2003US6583121 System for the in vivo delivery and expression of heterologous genes in the bone marrow
06/24/2003US6583116 Preventing gramnegative bacterial infections by administering synergystic mixtures of bactericidal/permeability-increasing (BPI) proteins and antibiotics
06/24/2003US6583115 Methods for treating acromegaly and giantism with growth hormone antagonists
06/24/2003US6583114 Fracture healing using pthrp analogs
06/24/2003US6583113 Additional smooth muscle relaxant and platelet inhibitory capabilities.
06/24/2003US6583112 Gene products related to werner's syndrome
06/24/2003US6583111 Use of GLP-1 analogs and derivative adminstered peripherally in regulation of obesity
06/24/2003US6583109 Domain/peptides/ contaning amino acid sequences of human chorionic gonadotrophin used for prevention and therapy of lymphadenopathy associated virus, as anticarcinogenic agents and/or to promote hematopoietic cells
06/24/2003US6583108 Human bikunin
06/24/2003US6583107 Hypersensitive response elicitor fragments eliciting a hypersensitive response and uses thereof
06/24/2003US6582968 Coupling spin probes such as 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid for immunoassay
06/24/2003US6582959 Antibodies to vascular endothelial cell growth factor
06/24/2003US6582956 Tumor suppressor gene
06/24/2003US6582950 C3 binding polypeptide of Streptococcus agalactiae group b Streptococcus
06/24/2003US6582949 Cephaibols: novel antiparasitics from Acremonium tubakii process for their production, and use thereof
06/24/2003US6582934 Recombinant DNA encoding an epidermal growth factor receptor related protein
06/24/2003US6582933 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of respiratory distress syndrome, asthma, organ rejection, inflammation, arthritis, ischemic, autoimmune, rheumatic and cancer disorders
06/24/2003US6582928 Carbohydrate-directed cross-linking reagents
06/24/2003US6582925 Desaturase antigen of mycobacterium tuberculosis
06/24/2003US6582918 Platelet derived growth factor (PDGF) nucleic acid ligand complexes
06/24/2003US6582915 Production of anti-self bodies from antibody segment repertories and displayed on phage
06/24/2003US6582913 Detection of nucleotide sequence polymorphism; obtain nucleotide sequences sampple, determine nucleotide sequence, compare to control, detect adjustment in nucleotide sequences
06/24/2003US6582911 Candida albicans KRE9 and uses thereof
06/24/2003US6582910 WbpP and method for assay of WbpP
06/24/2003US6582909 Genotyping biological sample; obtain sample, extract nucleotide sequence, sequence, compare to control, detect adjustments in sequences, score
06/24/2003US6582905 Cloning preerential nucleotide sequences; obtain nucleotide sequences, incubate with vector, cut with enzyme, seal with ligase, incubate vector with cells transform cells, recover transform cells, propagte, recover clones
06/24/2003US6582899 Methods for identifying agents that cause a lethal phenotype, and agents thereof
06/24/2003US6582706 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS
06/24/2003US6582705 Acellular antibordetella vaccine
06/24/2003US6582704 Immunogenic peptides from the HPV E7 protein
06/24/2003US6582703 Medical diagnosis; amplification primers; genetic engineering
06/24/2003US6582701 Equine Fc epsilon receptor alpha chain proteins and uses thereof
06/24/2003US6582700 Linear antigen supporting units
06/24/2003US6582697 Administering a synthetic conjugate comprising a carbohydrate antigenic determinant and an immunogenic carrier not naturally conjugated with said determinant; tumor prophylaxis and therapy for example
06/24/2003US6582693 Recombinant MVA virus expressing the E2 gene of Bovine papillomavirus and its use in the therapy of tumors generated by papillomaviruses
06/24/2003US6582691 Expression vector for the production of dead proteins
06/24/2003US6582689 Interferon- gamma -inducing factor (IGIF), in combination with a chemotherapeutic agent, processes for making such compositions, the use of such compositions for the prevention and/or treatment of cancer, and the use of such compositions
06/24/2003US6582618 Method of determining etch endpoint using principal components analysis of optical emission spectra
06/24/2003US6582603 Method for purifying thrombin substrate and/or inhibitors or method for eliminating the same
06/24/2003US6582391 Extracorporeal device comprising insoluble collagen fibrils; embedded within matrix are cultured vertebrate cells which secrete polypeptides; shunting patient's blood through apparatus and back into patient; polypeptide mixes with blood
06/24/2003CA2223694C Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
06/24/2003CA2171544C Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
06/24/2003CA2165566C Conotoxins having acetylcholin receptor binding properties
06/24/2003CA2100617C Liquid thromboplastin reagent
06/24/2003CA2047142C Skin test to human papillomavirus type 16
06/24/2003CA1341433C Purification of interleukin 1
06/22/2003CA2412226A1 Compositions, methods and systems for discovery of lipopeptides
06/21/2003CA2412187A1 Assay for identifying modulators of borrelia telomere resolvase
06/19/2003WO2003050542A2 Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit
06/19/2003WO2003050540A2 Flexible method and apparatus for high throughput production and purification of multiple proteins
06/19/2003WO2003050311A2 Methods and compositions for diagnosing and treating hypotrichosis simplex
06/19/2003WO2003050302A2 Tgnp activity or expression as marker for apoptosis
06/19/2003WO2003050301A2 Susceptibility locus for schizophrenia
06/19/2003WO2003050300A2 Diagnosis and treatment of cancer
06/19/2003WO2003050295A2 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003WO2003050293A2 hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY
06/19/2003WO2003050286A1 Methods and means for producing proteins with predetermined post-translational modifications
06/19/2003WO2003050284A1 Human prostate cancer candidate protein 1
06/19/2003WO2003050281A2 Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity
06/19/2003WO2003050280A1 Regulation of human fatty acid binding protein
06/19/2003WO2003050279A1 Human tumor related gene in region of sub-band 3 of band 3 of zone 1 of human chromosome 17 and detection kit
06/19/2003WO2003050268A2 Enhancement of the immune response using cd36-binding domain
06/19/2003WO2003050265A2 Compositions and methods for normalizing assays
06/19/2003WO2003050263A2 Dna encoding orphan snorf49 receptor
06/19/2003WO2003050260A2 Streptavidin expressed gene fusions and methods of use thereof
06/19/2003WO2003050259A2 Nucleic acids related to plant retroelements
06/19/2003WO2003050258A2 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003WO2003050256A2 Novel human g-protein coupled receptor, hgprbmy34, and variants and methods of use thereof
06/19/2003WO2003050254A2 Novel chimeric tnf ligands
06/19/2003WO2003050253A2 Proteins associated with cell growth, differentiation, and death
06/19/2003WO2003050245A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
06/19/2003WO2003050243A2 Novel genes encoding colon cancer antigens
06/19/2003WO2003050240A2 Expression system
06/19/2003WO2003050239A2 Crystals and structures of members of the e. coli coma and yddb protein families (coma)
06/19/2003WO2003050238A2 Receptor-targeted adenoviral vectors
06/19/2003WO2003050236A2 Human genes and gene expression products isolated from human prostate
06/19/2003WO2003050235A2 Polynucleotide encoding a novel human potassium channel alpha-subunit, k+alpham2
06/19/2003WO2003050233A2 Gene promoters
06/19/2003WO2003050143A1 Detection and removal of lead using lead-binding proteins
06/19/2003WO2003050142A1 Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides
06/19/2003WO2003050141A2 Calpain activators
06/19/2003WO2003050139A2 Prion inhibiting peptides and derivatives thereof
06/19/2003WO2003050135A2 Use a parapox b2l protein to modify immune responses to administered antigens
06/19/2003WO2003050134A2 Crystalline neutrokine-alpha protein, method of preparation thereof, and method of use thereof
06/19/2003WO2003049773A1 Methods for inhibiting ocular processes
06/19/2003WO2003049762A2 Immunisation against chlamydia trachomatis
06/19/2003WO2003049760A1 Compositions and method for treating hepatitis virus infection
06/19/2003WO2003049757A1 Agonists and antagonists of glucomin for the treatment of metabolic disorders
06/19/2003WO2003049703A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003WO2003049686A2 Stabilization of hypoxia inducible factor (hif) alpha
06/19/2003WO2003049684A2 Pseudo-antibody constructs
06/19/2003WO2003049683A2 Use of parapox b2l protein to treat cancer and modify immune responses
06/19/2003WO2003049602A2 Diagnostic methods for protein profiling
06/19/2003WO2003035681A3 Mycobacterial genes down-regulated during latency
06/19/2003WO2003027252A3 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
06/19/2003WO2002094996A8 Ccl1 polynucleotides and polypeptides and uses thereof
06/19/2003WO2002094864A3 Human cdnas and proteins and uses thereof
06/19/2003WO2002083914A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
1 ... 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 ... 2916